Skip to main content

Biologic Response Modification

  • Chapter
  • 141 Accesses

Abstract

Biologic response modifiers (BRM) are compounds that modify an immune response, usually enhancing it. They include immune-potentiating bacterial products, chemicals such as polynucleotides, physiologically active molecules such as thymic hormones and interferon, and the true adjuvants, which are administered with the antigen. A number of these substances have been used in an attempt to potentiate immune reactions in cancer patients and those who suffer from immunodeficiency.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Barber HRK: Biological response modification. Infec Dis Lett Obstet Gynecol 10 (1): 7, 1988.

    Google Scholar 

  • Barber HRK: Present status of tumor immunology in clinical gynecology. Am J Reprod Immunol 20 (4): 140, 1989.

    PubMed  CAS  Google Scholar 

  • Carter PW: Monoclonal antibodies and the biological approach to cancer. J Biol Response Modifiers 4: 325, 1985.

    CAS  Google Scholar 

  • Cherfas J: Man-made Life. Oxford, Basil Blackwell, 1982.

    Google Scholar 

  • Garnet MC, Embleton MJ, Jacobs E, Baldwin RW: Preparation and properties of drug carrier antibody and conjugate showing selective antibody directed cytotoxicity in vitro. Int J Cancer 31: 661, 1983.

    Article  Google Scholar 

  • Jackson DA, Stich MS (eds): Recombinant DNA Debate. Prentice-Hall, Englewood Cliffs, NJ, 1979.

    Google Scholar 

  • Kennet G, McKearn T (eds): Monoclonal Antibodies. Plenum Press, New York, 1980.

    Google Scholar 

  • Kohler G, Milstein C: Continuous culture of few cells secreting antibody of predefined specificity. Nature 256: 495, 1975.

    Article  PubMed  CAS  Google Scholar 

  • Lenard WJ, Depter JM, Kanehisa N, et al: Structure of the human interleukin-2 receptor gene. Science 230: 633, 1985.

    Article  Google Scholar 

  • McAuliffe S, McAuliffe K: Life for Sale. Coward, McCann & Goeghejan, New York, 1981.

    Google Scholar 

  • Moertel CG: On lymphokines, cytokines and breakthrough. JAMA 256: 341, 1986.

    Article  Google Scholar 

  • Wiseman A (ed): Principles of Biotechnology. Surrey: University Press, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Barber, H.R.K. (1993). Biologic Response Modification. In: Ovarian Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9232-3_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-9232-3_27

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-9234-7

  • Online ISBN: 978-1-4613-9232-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics